Boston Scientific Corporation Common Stock · Transaction Sep 9, 2026 · Filed Sep 25, 2026 · $50,001 to $100,000
XNYS · BSX
+0.57% · +$0.2500 · Vol Not reported
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Boston Scientific Corp.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$44.39
Follow $BSX
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $BSX by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredFri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET · BSX
MethodologyBSX
Boston Scientific Corp.
Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
58/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
AI Analysis
SovereignWhy is BSX moving today?
Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Boston Scientific Corp.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSListed since
1992
Employees
59K
Country
US
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$44.45
Day high
$44.83
Day low
$43.89
Previous close
$44.14
52W high
$104.98
-57.72% from high
52W low
$41.58
4% of range
Market cap
$64.3B
Beta
0.06
Shares out
1.4B
Avg volume
19.2M
VWAP
$44.14
Last session
Price history computed in-house
1W
+3.88%
1M
+2.42%
3M
+1.42%
1Y
-55.27%
YTD
-53.45%
SMA 50 $46.09 · below
SMA 200 $59.10 · below
52W position 4%
BSX overview
Related filings and maps
Public disclosures
Congress activity in BSX
19 filers · 41 buys · 56 sells (2 labeled S (partial)) · Mar 18, 2015 to Sep 9, 2026 · House 90 / Senate 7
All available history · Latest 5 of 97 lines · Read Oct 18, 2026, 9:14 AM UTC
Official filing ↗
Boston Scientific Corporation Common Stock · Transaction Sep 4, 2026 · Filed Sep 25, 2026 · $50,001 to $100,000
Boston Scientific Corporation Common Stock · Transaction Sep 3, 2026 · Filed Sep 25, 2026 · $1,001 to $15,000
Boston Scientific Corporation Common Stock · Transaction Sep 3, 2026 · Filed Sep 25, 2026 · $1,001 to $15,000
Boston Scientific Corporation Common Stock · Transaction Sep 3, 2026 · Filed Sep 25, 2026 · $1,001 to $15,000
Federal contracts
BSX contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BSX in this window.
Lobbying spend
BSX lobbying filings, year to date.
Registered lobbying filings matched to Boston Scientific Corp..
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BSX in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for BSX.